Thermoresponsive biodegradable polymers with tunable temperature-dependent solubility
Targeted drug delivery is being explored as an alternative to chemotherapy in cancer treatment. While many anti-cancer agents have been identified, applications have been limited due to temperature sensitivity and cytotoxicity of the carrier polymer. This technology describes methods for creating biodegradable polyacetal-based polymers with a specified lower critical solution temperature (LCST). This technology provides pathways for delivery of a range of novel pharmaceutical agents.
Simple chemical synthesis methodsHighly predictable and tunable release of cargo over a temperature range of 6-80°CRapid phase transition and release of cargo within 3-5°C targets hyperthermic cancer environmentsBiodegradable in mildly acidic conditionsNon-toxic byproducts after pH induced degradationControllable degradation conditionsPolymer chain-end functionality for versatility beyond cancer therapiesPatent Information:Patent Pending (WO/2016/090103)Tech Ventures Reference: IR CU14314
Anti-cancer therapeuticsTargeted drug deliveryTherapeutics for crops, plants or seeds
None
美國
